What’s Next for mRNA Vaccines?

January 5, 2023

(MIT Technology Review) – Moderna, the biotech company behind one of the two approved mRNA vaccines for covid-19, is developing mRNA vaccines for RSV (respiratory syncytial virus), HIV, Zika, Epstein-Barr virus, and more. BioNTech, which partnered with Pfizer on the other approved mRNA-based covid-19 vaccine, is exploring vaccines for tuberculosis, malaria, HIV, shingles, and flu. Both companies are working on treatments for cancer. And many other companies and academic labs are getting in on the action. (Read More)